Mpm Bioventures 2018, L.P.

Insider Reports History

Entity
Company
Location
450 Kendall Street, Cambridge, MA
Signature
/s/ Ansbert Gadicke, managing director of MPM BioVentures 2018 LLC, the managing member of MPM BioVentures 2018 GP LLC, the general partner of MPM BioVentures 2018, L.P.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mpm Bioventures 2018, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Entrada Therapeutics, Inc. 10%+ Owner Common Stock 4.43M $70.8M $15.99 Nov 2, 2021 Indirect
iTeos Therapeutics, Inc. 10%+ Owner Common Stock 2.74M $22.9M $8.37 Jan 5, 2022 Indirect
Entrada Therapeutics, Inc. 10%+ Owner Series A Preferred Stock 0 Nov 2, 2021 Indirect
Entrada Therapeutics, Inc. 10%+ Owner Series B Preferred Stock 0 Nov 2, 2021 Indirect

Insider Reports Filed by Mpm Bioventures 2018, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ITOS iTeos Therapeutics, Inc. Jan 4, 2022 5 -$6.25M 4 Jan 6, 2022 10%+ Owner
ITOS iTeos Therapeutics, Inc. Dec 3, 2021 9 -$1.68M 4 Dec 7, 2021 10%+ Owner
ITOS iTeos Therapeutics, Inc. Nov 30, 2021 7 -$2.88M 4 Dec 2, 2021 10%+ Owner
ITOS iTeos Therapeutics, Inc. Nov 26, 2021 4 -$811K 4 Nov 30, 2021 10%+ Owner
ITOS iTeos Therapeutics, Inc. Nov 17, 2021 8 -$2.84M 4 Nov 24, 2021 10%+ Owner
TRDA Entrada Therapeutics, Inc. Nov 2, 2021 5 $2M 4 Nov 4, 2021 10%+ Owner
TRDA Entrada Therapeutics, Inc. Oct 28, 2021 0 $0 3 Oct 28, 2021 10%+ Owner
ITOS iTeos Therapeutics, Inc. Oct 15, 2021 3 -$469K 4 Oct 18, 2021 10%+ Owner
ITOS iTeos Therapeutics, Inc. Oct 12, 2021 3 -$1.54M 4 Oct 14, 2021 10%+ Owner
ITOS iTeos Therapeutics, Inc. Oct 7, 2021 3 -$1.42M 4 Oct 12, 2021 10%+ Owner
ITOS iTeos Therapeutics, Inc. Oct 1, 2021 2 -$746K 4 Oct 5, 2021 10%+ Owner
ITOS iTeos Therapeutics, Inc. Sep 28, 2021 2 -$581K 4 Sep 30, 2021 10%+ Owner
ITOS iTeos Therapeutics, Inc. Sep 23, 2021 4 -$1.48M 4 Sep 27, 2021 10%+ Owner
ITOS iTeos Therapeutics, Inc. Sep 21, 2021 2 -$933K 4 Sep 23, 2021 10%+ Owner
ITOS iTeos Therapeutics, Inc. Sep 16, 2021 4 -$2.59M 4 Sep 20, 2021 10%+ Owner
ITOS iTeos Therapeutics, Inc. Sep 14, 2021 4 -$1.26M 4 Sep 16, 2021 10%+ Owner
ITOS iTeos Therapeutics, Inc. Sep 9, 2021 4 -$1.63M 4 Sep 13, 2021 10%+ Owner
ITOS iTeos Therapeutics, Inc. Sep 7, 2021 4 -$1.24M 4 Sep 8, 2021 10%+ Owner